JP3814314B2 - Ｎａｄｈ、ｎａｄｐｈ又はその類似体の電気化学的再生に適した仲介物質 - Google Patents

Ｎａｄｈ、ｎａｄｐｈ又はその類似体の電気化学的再生に適した仲介物質 Download PDF

Info

Publication number: JP3814314B2
Authority: JP; Japan
Prior art keywords: mediator; electrode according; formula; electrode; substituted
Prior art date: 1994-09-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

JP25043395A

Other languages

English (en)

Japanese (ja)

Other versions

JPH08100284A (ja

Inventor

ポール・エフ・コーリー

マシュー・ケー・ムショー

Original Assignee

バイエルコーポレーション

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-29

Filing date

1995-09-28

Publication date

2006-08-30

1995-09-28 Application filed by バイエルコーポレーション filed Critical バイエルコーポレーション

1996-04-16 Publication of JPH08100284A publication Critical patent/JPH08100284A/ja

2006-08-30 Application granted granted Critical

2006-08-30 Publication of JP3814314B2 publication Critical patent/JP3814314B2/ja

2015-09-28 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 title claims description 27
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 title claims description 18
230000008929 regeneration Effects 0.000 title claims description 9
238000011069 regeneration method Methods 0.000 title claims description 9
ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 title claims 2
150000001875 compounds Chemical class 0.000 claims description 28
239000005515 coenzyme Substances 0.000 claims description 13
-1 2-benzoxazolyl Chemical group 0.000 claims description 11
125000001424 substituent group Chemical group 0.000 claims description 9
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
125000003118 aryl group Chemical group 0.000 claims description 8
229930194542 Keto Natural products 0.000 claims description 6
239000010439 graphite Substances 0.000 claims description 6
229910002804 graphite Inorganic materials 0.000 claims description 6
125000001931 aliphatic group Chemical group 0.000 claims description 5
XIYJCVOQLOVRKQ-UHFFFAOYSA-N 3-methylidenephenothiazine Chemical class C1=CC=C2SC3=CC(=C)C=CC3=NC2=C1 XIYJCVOQLOVRKQ-UHFFFAOYSA-N 0.000 claims description 4
GPBDWNTVPOFRDX-UHFFFAOYSA-N 3-methylidenephenoxazine Chemical class C1=CC=C2OC3=CC(=C)C=CC3=NC2=C1 GPBDWNTVPOFRDX-UHFFFAOYSA-N 0.000 claims description 4
BOPGDPNILDQYTO-NNYOXOHSSA-L NADH(2-) Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-L 0.000 claims description 4
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
125000003545 alkoxy group Chemical group 0.000 claims description 3
150000001408 amides Chemical class 0.000 claims description 3
125000004432 carbon atom Chemical group C* 0.000 claims description 3
125000004122 cyclic group Chemical group 0.000 claims description 3
125000006575 electron-withdrawing group Chemical group 0.000 claims description 3
125000000524 functional group Chemical group 0.000 claims description 3
229910052736 halogen Inorganic materials 0.000 claims description 3
150000002367 halogens Chemical class 0.000 claims description 3
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
229910019142 PO4 Inorganic materials 0.000 claims description 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 2
125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 2
125000005135 aryl sulfinyl group Chemical group 0.000 claims description 2
125000004391 aryl sulfonyl group Chemical group 0.000 claims description 2
125000004104 aryloxy group Chemical group 0.000 claims description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
229910052794 bromium Inorganic materials 0.000 claims description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
229910052801 chlorine Inorganic materials 0.000 claims description 2
239000000460 chlorine Substances 0.000 claims description 2
125000004093 cyano group Chemical group *C#N 0.000 claims description 2
150000003950 cyclic amides Chemical class 0.000 claims description 2
HBGGXOJOCNVPFY-UHFFFAOYSA-N diisononyl phthalate Chemical compound CC(C)CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC(C)C HBGGXOJOCNVPFY-UHFFFAOYSA-N 0.000 claims description 2
239000007772 electrode material Substances 0.000 claims description 2
229910052731 fluorine Inorganic materials 0.000 claims description 2
239000011737 fluorine Substances 0.000 claims description 2
229910021397 glassy carbon Inorganic materials 0.000 claims description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
229910052737 gold Inorganic materials 0.000 claims description 2
239000010931 gold Substances 0.000 claims description 2
229910052739 hydrogen Inorganic materials 0.000 claims description 2
239000001257 hydrogen Substances 0.000 claims description 2
125000000468 ketone group Chemical group 0.000 claims description 2
125000001624 naphthyl group Chemical group 0.000 claims description 2
229910052760 oxygen Inorganic materials 0.000 claims description 2
239000001301 oxygen Substances 0.000 claims description 2
125000005062 perfluorophenyl group Chemical group FC1=C(C(=C(C(=C1F)F)F)F)* 0.000 claims description 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
239000010452 phosphate Substances 0.000 claims description 2
229910052697 platinum Inorganic materials 0.000 claims description 2
125000006684 polyhaloalkyl group Polymers 0.000 claims description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
125000004076 pyridyl group Chemical group 0.000 claims description 2
239000002296 pyrolytic carbon Substances 0.000 claims description 2
229910052717 sulfur Inorganic materials 0.000 claims description 2
239000011593 sulfur Substances 0.000 claims description 2
125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 claims description 2
MUCRYNWJQNHDJH-OADIDDRXSA-N Ursonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C MUCRYNWJQNHDJH-OADIDDRXSA-N 0.000 claims 1
125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 48
239000000243 solution Substances 0.000 description 19
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 11
238000006243 chemical reaction Methods 0.000 description 11
239000008103 glucose Substances 0.000 description 11
PAMLBFCULUAAIX-UHFFFAOYSA-N 2-(8-chlorophenothiazin-3-ylidene)propanedinitrile Chemical compound N#CC(C#N)=C1C=CC2=NC3=CC(Cl)=CC=C3SC2=C1 PAMLBFCULUAAIX-UHFFFAOYSA-N 0.000 description 7
108090000790 Enzymes Proteins 0.000 description 7
102000004190 Enzymes Human genes 0.000 description 7
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 7
101710088194 Dehydrogenase Proteins 0.000 description 6
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 6
229950006238 nadide Drugs 0.000 description 6
229950000688 phenothiazine Drugs 0.000 description 6
239000000758 substrate Substances 0.000 description 6
WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 5
229910021607 Silver chloride Inorganic materials 0.000 description 4
238000000034 method Methods 0.000 description 4
230000003647 oxidation Effects 0.000 description 4
238000007254 oxidation reaction Methods 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 4
239000007787 solid Substances 0.000 description 4
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
230000002378 acidificating effect Effects 0.000 description 3
238000009835 boiling Methods 0.000 description 3
150000001721 carbon Chemical group 0.000 description 3
229910052799 carbon Inorganic materials 0.000 description 3
238000001914 filtration Methods 0.000 description 3
150000002500 ions Chemical class 0.000 description 3
229910052709 silver Inorganic materials 0.000 description 3
239000004332 silver Substances 0.000 description 3
UHKAJLSKXBADFT-UHFFFAOYSA-N 1,3-indandione Chemical compound C1=CC=C2C(=O)CC(=O)C2=C1 UHKAJLSKXBADFT-UHFFFAOYSA-N 0.000 description 2
TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 2
RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
108020005199 Dehydrogenases Proteins 0.000 description 2
108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 2
DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
239000007990 PIPES buffer Substances 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
BADXJIPKFRBFOT-UHFFFAOYSA-N dimedone Chemical compound CC1(C)CC(=O)CC(=O)C1 BADXJIPKFRBFOT-UHFFFAOYSA-N 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
238000005691 oxidative coupling reaction Methods 0.000 description 2
230000001590 oxidative effect Effects 0.000 description 2
235000011056 potassium acetate Nutrition 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
150000003222 pyridines Chemical class 0.000 description 2
239000000126 substance Substances 0.000 description 2
RFTDSROCIOTWSP-UHFFFAOYSA-N (3-amino-2-methylphenyl)-naphthalen-2-ylmethanone Chemical compound C1=C(C=CC2=CC=CC=C12)C(=O)C1=C(C(N)=CC=C1)C RFTDSROCIOTWSP-UHFFFAOYSA-N 0.000 description 1
PVPBBTJXIKFICP-UHFFFAOYSA-N (7-aminophenothiazin-3-ylidene)azanium;chloride Chemical compound [Cl-].C1=CC(=[NH2+])C=C2SC3=CC(N)=CC=C3N=C21 PVPBBTJXIKFICP-UHFFFAOYSA-N 0.000 description 1
WOAHJDHKFWSLKE-UHFFFAOYSA-N 1,2-benzoquinone Chemical compound O=C1C=CC=CC1=O WOAHJDHKFWSLKE-UHFFFAOYSA-N 0.000 description 1
VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
IFKVERMEMGDLLL-UHFFFAOYSA-N 2-(10h-phenothiazin-2-yl)acetic acid Chemical compound C1=CC=C2NC3=CC(CC(=O)O)=CC=C3SC2=C1 IFKVERMEMGDLLL-UHFFFAOYSA-N 0.000 description 1
KFZGLJSYQXZIGP-UHFFFAOYSA-N 2-chloro-10h-phenothiazine Chemical compound C1=CC=C2NC3=CC(Cl)=CC=C3SC2=C1 KFZGLJSYQXZIGP-UHFFFAOYSA-N 0.000 description 1
XRBFSIULXQASEB-UHFFFAOYSA-N 2h-phenazin-1-one Chemical compound C1=CC=C2N=C3C(=O)CC=CC3=NC2=C1 XRBFSIULXQASEB-UHFFFAOYSA-N 0.000 description 1
FIICCGOYRVMEPV-UHFFFAOYSA-N 3H-phenothiazine Chemical compound C1=CC=C2SC3=CCC=CC3=NC2=C1 FIICCGOYRVMEPV-UHFFFAOYSA-N 0.000 description 1
MOLUAYHPIDORGD-UHFFFAOYSA-N 3h-phenoxazine Chemical compound C1=CC=C2OC3=CCC=CC3=NC2=C1 MOLUAYHPIDORGD-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000002411 adverse Effects 0.000 description 1
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
PCNDJXKNXGMECE-UHFFFAOYSA-P c1ccc2[nH+]c3ccccc3[nH+]c2c1 Chemical compound c1ccc2[nH+]c3ccccc3[nH+]c2c1 PCNDJXKNXGMECE-UHFFFAOYSA-P 0.000 description 1
238000011088 calibration curve Methods 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
239000000539 dimer Substances 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000446 fuel Substances 0.000 description 1
125000005842 heteroatom Chemical group 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
235000019239 indanthrene blue RS Nutrition 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
239000011630 iodine Substances 0.000 description 1
IAQLJCYTGRMXMA-UHFFFAOYSA-M lithium;acetate;dihydrate Chemical compound [Li+].O.O.CC([O-])=O IAQLJCYTGRMXMA-UHFFFAOYSA-M 0.000 description 1
CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 description 1
239000000463 material Substances 0.000 description 1
GXHFUVWIGNLZSC-UHFFFAOYSA-N meldrum's acid Chemical compound CC1(C)OC(=O)CC(=O)O1 GXHFUVWIGNLZSC-UHFFFAOYSA-N 0.000 description 1
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
239000000203 mixture Substances 0.000 description 1
229960003966 nicotinamide Drugs 0.000 description 1
235000005152 nicotinamide Nutrition 0.000 description 1
239000011570 nicotinamide Substances 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
239000012038 nucleophile Substances 0.000 description 1
239000007800 oxidant agent Substances 0.000 description 1
125000004430 oxygen atom Chemical group O* 0.000 description 1
239000002245 particle Substances 0.000 description 1
VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical class OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
150000002990 phenothiazines Chemical class 0.000 description 1
FIZIRKROSLGMPL-UHFFFAOYSA-N phenoxazin-1-one Chemical class C1=CC=C2N=C3C(=O)C=CC=C3OC2=C1 FIZIRKROSLGMPL-UHFFFAOYSA-N 0.000 description 1
UOMHBFAJZRZNQD-UHFFFAOYSA-N phenoxazin-3-one Chemical compound C1=CC=C2OC3=CC(=O)C=CC3=NC2=C1 UOMHBFAJZRZNQD-UHFFFAOYSA-N 0.000 description 1
150000002991 phenoxazines Chemical class 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
238000005498 polishing Methods 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
150000005839 radical cations Chemical class 0.000 description 1
238000010405 reoxidation reaction Methods 0.000 description 1
230000027756 respiratory electron transport chain Effects 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000001308 synthesis method Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Images

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/004—Enzyme electrodes mediator-assisted
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/817—Enzyme or microbe electrode

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Mycology (AREA)
Physics & Mathematics (AREA)
General Chemical & Material Sciences (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
Inert Electrodes (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

JP25043395A 1994-09-29 1995-09-28 Ｎａｄｈ、ｎａｄｐｈ又はその類似体の電気化学的再生に適した仲介物質 Expired - Fee Related JP3814314B2 (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/314,718 US5498542A (en)	1994-09-29	1994-09-29	Electrode mediators for regeneration of NADH and NADPH
US08/314718		1994-09-29

Publications (2)

Publication Number	Publication Date
JPH08100284A JPH08100284A (ja)	1996-04-16
JP3814314B2 true JP3814314B2 (ja)	2006-08-30

Family

ID=23221146

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP25043395A Expired - Fee Related JP3814314B2 (ja)	1994-09-29	1995-09-28	Ｎａｄｈ、ｎａｄｐｈ又はその類似体の電気化学的再生に適した仲介物質

Country Status (6)

Country	Link
US (1)	US5498542A (de)
EP (1)	EP0704535B1 (de)
JP (1)	JP3814314B2 (de)
AU (1)	AU689630B2 (de)
CA (1)	CA2152410C (de)
DE (1)	DE69524175T2 (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5498542A (en) *	1994-09-29	1996-03-12	Bayer Corporation	Electrode mediators for regeneration of NADH and NADPH
US5866353A (en) *	1996-12-09	1999-02-02	Bayer Corporation	Electro chemical biosensor containing diazacyanine mediator for co-enzyme regeneration
US6036924A (en)	1997-12-04	2000-03-14	Hewlett-Packard Company	Cassette of lancet cartridges for sampling blood
US6391005B1 (en)	1998-03-30	2002-05-21	Agilent Technologies, Inc.	Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6500571B2 (en) *	1998-08-19	2002-12-31	Powerzyme, Inc.	Enzymatic fuel cell
US8641644B2 (en)	2000-11-21	2014-02-04	Sanofi-Aventis Deutschland Gmbh	Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US7041068B2 (en)	2001-06-12	2006-05-09	Pelikan Technologies, Inc.	Sampling module device and method
US9226699B2 (en)	2002-04-19	2016-01-05	Sanofi-Aventis Deutschland Gmbh	Body fluid sampling module with a continuous compression tissue interface surface
AU2002348683A1 (en)	2001-06-12	2002-12-23	Pelikan Technologies, Inc.	Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
ATE497731T1 (de)	2001-06-12	2011-02-15	Pelikan Technologies Inc	Gerät zur erhöhung der erfolgsrate im hinblick auf die durch einen fingerstich erhaltene blutausbeute
ATE485766T1 (de)	2001-06-12	2010-11-15	Pelikan Technologies Inc	Elektrisches betätigungselement für eine lanzette
ES2336081T3 (es)	2001-06-12	2010-04-08	Pelikan Technologies Inc.	Dispositivo de puncion de auto-optimizacion con medios de adaptacion a variaciones temporales en las propiedades cutaneas.
AU2002312521A1 (en)	2001-06-12	2002-12-23	Pelikan Technologies, Inc.	Blood sampling apparatus and method
US8337419B2 (en)	2002-04-19	2012-12-25	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
CA2448681C (en)	2001-06-12	2014-09-09	Pelikan Technologies, Inc.	Integrated blood sampling analysis system with multi-use sampling module
US9427532B2 (en)	2001-06-12	2016-08-30	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
US7981056B2 (en)	2002-04-19	2011-07-19	Pelikan Technologies, Inc.	Methods and apparatus for lancet actuation
US9795747B2 (en)	2010-06-02	2017-10-24	Sanofi-Aventis Deutschland Gmbh	Methods and apparatus for lancet actuation
WO2002100843A1 (en) *	2001-06-13	2002-12-19	Jianqing Lu	Phenoxazine compounds, the compositions containing them and their medicinal uses
US7344894B2 (en)	2001-10-16	2008-03-18	Agilent Technologies, Inc.	Thermal regulation of fluidic samples within a diagnostic cartridge
US7291117B2 (en)	2002-04-19	2007-11-06	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7491178B2 (en)	2002-04-19	2009-02-17	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7563232B2 (en)	2002-04-19	2009-07-21	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US9314194B2 (en)	2002-04-19	2016-04-19	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
US7175642B2 (en)	2002-04-19	2007-02-13	Pelikan Technologies, Inc.	Methods and apparatus for lancet actuation
US8702624B2 (en)	2006-09-29	2014-04-22	Sanofi-Aventis Deutschland Gmbh	Analyte measurement device with a single shot actuator
US7331931B2 (en)	2002-04-19	2008-02-19	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US9248267B2 (en)	2002-04-19	2016-02-02	Sanofi-Aventis Deustchland Gmbh	Tissue penetration device
US7226461B2 (en) *	2002-04-19	2007-06-05	Pelikan Technologies, Inc.	Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7232451B2 (en)	2002-04-19	2007-06-19	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7244265B2 (en)	2002-04-19	2007-07-17	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7648468B2 (en) *	2002-04-19	2010-01-19	Pelikon Technologies, Inc.	Method and apparatus for penetrating tissue
US7909778B2 (en)	2002-04-19	2011-03-22	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7485128B2 (en)	2002-04-19	2009-02-03	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US8372016B2 (en)	2002-04-19	2013-02-12	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for body fluid sampling and analyte sensing
US7410468B2 (en)	2002-04-19	2008-08-12	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US8784335B2 (en)	2002-04-19	2014-07-22	Sanofi-Aventis Deutschland Gmbh	Body fluid sampling device with a capacitive sensor
US7374544B2 (en)	2002-04-19	2008-05-20	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7892183B2 (en)	2002-04-19	2011-02-22	Pelikan Technologies, Inc.	Method and apparatus for body fluid sampling and analyte sensing
US7976476B2 (en)	2002-04-19	2011-07-12	Pelikan Technologies, Inc.	Device and method for variable speed lancet
US7141058B2 (en)	2002-04-19	2006-11-28	Pelikan Technologies, Inc.	Method and apparatus for a body fluid sampling device using illumination
US7717863B2 (en)	2002-04-19	2010-05-18	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
EP1501402A4 (de)	2002-04-19	2008-07-02	Pelikan Technologies Inc	Vorrichtung und verfahren für eine lanzette mit variabler geschwindigkeit
US8579831B2 (en)	2002-04-19	2013-11-12	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US9795334B2 (en)	2002-04-19	2017-10-24	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US7582099B2 (en)	2002-04-19	2009-09-01	Pelikan Technologies, Inc	Method and apparatus for penetrating tissue
US7229458B2 (en)	2002-04-19	2007-06-12	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7297122B2 (en)	2002-04-19	2007-11-20	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7371247B2 (en)	2002-04-19	2008-05-13	Pelikan Technologies, Inc	Method and apparatus for penetrating tissue
US8221334B2 (en)	2002-04-19	2012-07-17	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US8360992B2 (en)	2002-04-19	2013-01-29	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US7547287B2 (en)	2002-04-19	2009-06-16	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US8267870B2 (en)	2002-04-19	2012-09-18	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for body fluid sampling with hybrid actuation
US7901362B2 (en)	2002-04-19	2011-03-08	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7524293B2 (en)	2002-04-19	2009-04-28	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7674232B2 (en)	2002-04-19	2010-03-09	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7265881B2 (en) *	2002-12-20	2007-09-04	Hewlett-Packard Development Company, L.P.	Method and apparatus for measuring assembly and alignment errors in sensor assemblies
US8574895B2 (en)	2002-12-30	2013-11-05	Sanofi-Aventis Deutschland Gmbh	Method and apparatus using optical techniques to measure analyte levels
EP1628567B1 (de)	2003-05-30	2010-08-04	Pelikan Technologies Inc.	Verfahren und vorrichtung zur injektion von flüssigkeit
EP1633235B1 (de)	2003-06-06	2014-05-21	Sanofi-Aventis Deutschland GmbH	Gerät für die entnahme von körperflüssigkeiten und analyten-nachweis
WO2006001797A1 (en)	2004-06-14	2006-01-05	Pelikan Technologies, Inc.	Low pain penetrating
US7604592B2 (en)	2003-06-13	2009-10-20	Pelikan Technologies, Inc.	Method and apparatus for a point of care device
EP1671096A4 (de)	2003-09-29	2009-09-16	Pelikan Technologies Inc	Verfahren und apparatur für eine verbesserte probeneinfangvorrichtung
US9351680B2 (en)	2003-10-14	2016-05-31	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for a variable user interface
US7822454B1 (en)	2005-01-03	2010-10-26	Pelikan Technologies, Inc.	Fluid sampling device with improved analyte detecting member configuration
EP1706026B1 (de)	2003-12-31	2017-03-01	Sanofi-Aventis Deutschland GmbH	Verfahren und vorrichtung zur verbesserung der fluidströmung und der probennahme
WO2006011062A2 (en)	2004-05-20	2006-02-02	Albatros Technologies Gmbh & Co. Kg	Printable hydrogel for biosensors
WO2005120365A1 (en)	2004-06-03	2005-12-22	Pelikan Technologies, Inc.	Method and apparatus for a fluid sampling device
US9775553B2 (en) *	2004-06-03	2017-10-03	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for a fluid sampling device
US8652831B2 (en)	2004-12-30	2014-02-18	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for analyte measurement test time
EP3543348B1 (de) *	2006-09-22	2020-11-18	Ascensia Diabetes Care Holdings AG	Biosensorsystem mit verbesserter stabilität und hämatokrit-ausführung
EP3753481B1 (de)	2006-10-24	2024-07-17	Ascensia Diabetes Care Holdings AG	Nachwirkungsstrommessungsgerät
CA2700507C (en)	2007-09-24	2018-05-29	Bayer Healthcare Llc	Multi-region and potential test sensors, methods, and systems
EP3369825B1 (de)	2007-12-10	2021-07-28	Ascensia Diabetes Care Holdings AG	Poröse partikelreagenzzusammensetzungen und vorrichtungen für biosensoren
JP5856371B2 (ja)	2007-12-10	2016-02-09	バイエル・ヘルスケア・エルエルシーＢａｙｅｒＨｅａｌｔｈＣａｒｅＬＬＣ	分析対象物を検出するための試薬及び方法
WO2009076268A1 (en) *	2007-12-10	2009-06-18	Bayer Healthcare Llc	Process of making 3-phenylimino-3h-phenothiazine or 3-phenylimino-3h-phenoxazine mediator
US8008037B2 (en)	2008-03-27	2011-08-30	Roche Diagnostics Operations, Inc.	Matrix composition with alkylphenazine quaternary salt and a nitrosoaniline
WO2009126900A1 (en)	2008-04-11	2009-10-15	Pelikan Technologies, Inc.	Method and apparatus for analyte detecting device
CN105353013B (zh)	2008-07-10	2020-01-14	安晟信医疗科技控股公司	识别样本中的电离物质的方法
JP5773883B2 (ja)	2008-12-08	2015-09-02	バイエル・ヘルスケア・エルエルシーＢａｙｅｒＨｅａｌｔｈＣａｒｅＬＬＣ	バイオセンサのための低全塩試薬組成物およびシステム
US9375169B2 (en)	2009-01-30	2016-06-28	Sanofi-Aventis Deutschland Gmbh	Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8283347B2 (en) *	2009-06-01	2012-10-09	Bayer Healthcare Llc	Redox molecules and methods of making the same
WO2011059670A1 (en)	2009-11-10	2011-05-19	Bayer Healthcare Llc	Underfill recognition system for a biosensor
WO2011084607A1 (en)	2009-12-17	2011-07-14	Bayer Healthcare Llc	Transdermal systems, devices, and methods for biological analysis
WO2011075575A1 (en)	2009-12-17	2011-06-23	Bayer Healthcare Llc	Transdermal systems, devices, and methods to optically analyze an analyte
US9233788B2 (en)	2010-01-22	2016-01-12	Bayer Healthcare Llc	Biosensor desiccant system having enhanced measurement performance
US8965476B2 (en)	2010-04-16	2015-02-24	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
WO2011150155A1 (en)	2010-05-28	2011-12-01	Bayer Healthcare Llc	Polymer bonded redox molecules and methods of making the same
TWI565943B (zh)	2011-07-22	2017-01-11	拜耳保健公司	具有增進測量性能之生物感測器乾燥劑系統
JP6427110B2 (ja)	2013-01-28	2018-11-21	エフホフマン−ラロッシュアクチェンゲゼルシャフト	アスペルギルスニガー由来の新規グルコース酸化酵素
EP3183246B1 (de)	2014-08-22	2020-09-23	Roche Diagnostics GmbH	Redoxindikatoren
CN110642845B (zh) *	2019-09-30	2021-01-05	中国人民解放军军事科学院军事医学研究院	一种喹啉衍生物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0076266B1 (de) *	1981-04-08	1988-11-09	GORTON, Lo	Elektrode zum elektrochemischen regenerieren von koenzymen, verfahren zur herstellung dieser elektrode sowie deren verwendung
GB8424709D0 (en) *	1984-10-01	1984-11-07	Minnesota Mining & Mfg	Azine redox dyes and leuco azine dyes
IL102930A (en) *	1992-08-25	1997-03-18	Yissum Res Dev Co	Electrobiochemical analytical method and electrodes
US5393615A (en) *	1994-02-03	1995-02-28	Miles Inc.	Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof
US5498542A (en) *	1994-09-29	1996-03-12	Bayer Corporation	Electrode mediators for regeneration of NADH and NADPH
JPH08304329A (ja) *	1995-05-09	1996-11-22	Kdk Corp	多孔性膜を使用したバイオセンサー、および該多孔性膜の製造方法

1994
- 1994-09-29 US US08/314,718 patent/US5498542A/en not_active Expired - Lifetime
1995
- 1995-06-22 CA CA002152410A patent/CA2152410C/en not_active Expired - Fee Related
- 1995-09-18 DE DE69524175T patent/DE69524175T2/de not_active Expired - Lifetime
- 1995-09-18 EP EP95114633A patent/EP0704535B1/de not_active Expired - Lifetime
- 1995-09-27 AU AU32936/95A patent/AU689630B2/en not_active Ceased
- 1995-09-28 JP JP25043395A patent/JP3814314B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JPH08100284A (ja)	1996-04-16
US5498542A (en)	1996-03-12
DE69524175D1 (de)	2002-01-10
AU689630B2 (en)	1998-04-02
CA2152410C (en)	2004-02-17
CA2152410A1 (en)	1996-03-30
DE69524175T2 (de)	2002-05-02
AU3293695A (en)	1996-04-18
EP0704535A2 (de)	1996-04-03
EP0704535A3 (de)	1997-07-16
EP0704535B1 (de)	2001-11-28

Legal Events

Date	Code	Title	Description
2005-03-28	A977	Report on retrieval	Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050328
2005-07-27	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050726
2005-09-08	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050907
2006-05-25	TRDD	Decision of grant or rejection written
2006-05-31	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060530
2006-06-08	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060605
2006-06-09	R150	Certificate of patent or registration of utility model	Free format text: JAPANESE INTERMEDIATE CODE: R150
2009-06-04	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20090609 Year of fee payment: 3
2009-06-09	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20100609 Year of fee payment: 4
2010-05-27	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20100609 Year of fee payment: 4
2010-06-01	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20110609 Year of fee payment: 5
2011-05-31	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20120609 Year of fee payment: 6
2012-06-09	LAPS	Cancellation because of no payment of annual fees

Publication	Publication Date	Title
JP3814314B2 (ja)	2006-08-30	Ｎａｄｈ、ｎａｄｐｈ又はその類似体の電気化学的再生に適した仲介物質
JP3585552B2 (ja)	2004-11-04	Ｎａｄｈ、ｎａｄｐｈ又はその類似体の電気化学的再生に適した媒介物質
JP3831008B2 (ja)	2006-10-11	Ｎａｄｈ、ｎａｄｐｈ及びそれらの類似体の電気化学的再生に適切なメディエーター
KR940008083B1 (ko)	1994-09-01	분석물 또는 산화환원효소의 전기화학적 결정을 위한 방법 및 센서 전극장치 뿐만아니라 그에 대해 적당한 화합물의 용도
US10761045B2 (en)	2020-09-01	Sensor, sensor system, method of manufacturing sensor, and method of measuring concentration of target substance
JP3966591B2 (ja)	2007-08-29	電気化学的バイオセンサに有用である媒介物質
Cass et al.	1984	Ferrocene-mediated enzyme electrode for amperometric determination of glucose
US5846702A (en)	1998-12-08	Reagent including an osmium-containing redox mediator
US7544438B2 (en)	2009-06-09	Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode
US11905547B2 (en)	2024-02-20	Reagents for electrochemical test strips
EP0289345A1 (de)	1988-11-02	Ampérometrische Methode zur Titration von NADH (1,4 dihydronicotinamid-adenine-dinucleotide) in Lösung
JP3713049B2 (ja)	2005-11-02	オスミウム含有レドックスメディエーター
EP3131882B1 (de)	2020-07-15	Phenaziniummediatoren
JPH09297121A (ja)	1997-11-18	コレステロールセンサ
Kulys et al.	1998	Employing heterocyclic dihydropolyazines for amperometric glucose sensing
LAPĖNAITĖ et al.	2004	Some quinone derivatives as redox mediators for PQQ-dependent glucose dehydrogenase
KR102547109B1 (ko)	2023-06-23	신규한 유기 전자전달매개체 및 이를 포함하는 장치